Walpar Nutritions Limited (NSE:WALPAR)
India
· Delayed Price · Currency is INR 37.00
-1.10 (-2.89%)
At close: Apr 28, 2026
Walpar Nutritions Revenue
Walpar Nutritions had revenue of 366.21M INR in the half year ending September 30, 2025, with 17.38% growth. This brings the company's revenue in the last twelve months to 757.46M, up 17.66% year-over-year. In the fiscal year ending March 31, 2025, Walpar Nutritions had annual revenue of 719.60M with 14.93% growth.
Revenue (ttm)
757.46M
Revenue Growth
+17.66%
P/S Ratio
0.46
Revenue / Employee
n/a
Employees
n/a
Market Cap
347.45M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| ANG Lifesciences India | 862.13M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 671.50M |
| Gujarat Terce Laboratories | 483.98M |
| Panjon | 493.34M |
| Mangalam Drugs & Organics | 2.38B |